Read More Pharma Industry News Novo Nordisk’s $1.8bn acquisition of Emisphere Technologies: What it means for the future of oral biologics Danish pharmaceutical giant Novo Nordisk has reached a significant milestone in the development of oral biologic therapies, agreeing… bypharmanewsdailyNovember 6, 2020
